Tag Archives: Most

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the 2020 Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator. The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available… Read More »

How to be charismatic – 7 steps to becoming your most confident self

Charisma – you either have or don’t, right? Well, class is in session as Kevin Murray, author of Charismatic Leadership, breaks down how you can become more confident Being charismatic is often seen as having a ‘magnetic’ personality that can attract and inspire those around you. There are many kinds of charisma, many different definitions… Read More »

Loneliness is on the rise and younger workers and social media users feel it most, Cigna survey finds

It is often said that it’s lonely at the top, but loneliness on the job is a growing issue well beyond the corner office. American workers are feeling more isolated, and younger workers are experiencing loneliness more so than their older co-workers, according to a new Cigna study. Three out of every five adults, or… Read More »

This is ‘the most important decision’ the FDA will make in 2020, says analyst

The Food and Drug Administration‘s call on whether to approve Biogen‘s experimental Alzheimer’s drug, aducanumab, will be the “most important decision” the federal regulator will make in 2020, Bernstein analyst Ronny Gal said Friday. When asked if he thought the FDA would approve the drug, Gal said, “Yes.” “[But] you’ve got to be cautious about… Read More »

World’s most expensive drug costs $US2m

Gene therapy drug Zolgensma has become the world’s most expensive drug, with the one-time treatment priced at $ US2.1255 million ($ A3 million). Swiss drugmaker Novartis has won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants. Novartis executives defended the price, saying that… Read More »